Addex Therapeutics Ltd. business relationships
Companies named in Addex Therapeutics Ltd.’s 20-F filed 2026-05-15, and public companies whose annual reports name Addex Therapeutics Ltd.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.0 / 10
- AI naming
- 19 / 100 Top 2% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Addex Therapeutics Ltd.’s annual report 2
“License Agreement between Indivior UK Limited and the Registrant, dated January 2, 2018” SEC filing
“The Group retained its partnerships with Janssen Pharmaceuticals, Inc. and Indivior PLC, as well as unpartnered clinical stage assets including dipraglurant for Parkinson's disease and post-stroke/TBI recovery and its preclinical GABAB PAM program for chronic cough.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.